AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 52 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,142,236 | -20.9% | 8,263,982 | 0.0% | 2.21% | -17.5% |
| Q2 2023 | $141,727,291 | -15.0% | 8,263,982 | 0.0% | 2.68% | -29.1% |
| Q1 2023 | $166,684,517 | -31.2% | 8,263,982 | 0.0% | 3.77% | -23.2% |
| Q4 2022 | $242,134,673 | +76.7% | 8,263,982 | 0.0% | 4.91% | +68.0% |
| Q3 2022 | $137,017,000 | +6.1% | 8,263,982 | 0.0% | 2.92% | -15.1% |
| Q2 2022 | $129,166,000 | -14.7% | 8,263,982 | 0.0% | 3.44% | +4.2% |
| Q1 2022 | $151,479,000 | +55.5% | 8,263,982 | 0.0% | 3.30% | +92.4% |
| Q4 2021 | $97,432,000 | -43.8% | 8,263,982 | 0.0% | 1.72% | -28.5% |
| Q3 2021 | $173,378,000 | -8.1% | 8,263,982 | 0.0% | 2.40% | -20.7% |
| Q2 2021 | $188,667,000 | – | 8,263,982 | – | 3.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $17,690,227 | 28.88% |
| Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59,113,365 | 7.12% |
| Sofinnova Investments, Inc. | 3,758,686 | $110,129,500 | 6.54% |
| TCG Crossover Management, LLC | 1,081,274 | $31,681,328 | 5.59% |
| RA Capital Management | 8,263,982 | $242,134,673 | 4.91% |
| Cormorant Asset Management, LP | 1,957,132 | $57,344 | 3.84% |
| VR Adviser, LLC | 747,869 | $21,912,562 | 3.69% |
| Octagon Capital Advisors LP | 621,712 | $18,216,162 | 2.84% |
| GREAT POINT PARTNERS LLC | 378,522 | $11,090,695 | 2.17% |
| Ghost Tree Capital, LLC | 135,000 | $3,956,000 | 1.69% |